Cargando…
Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells
BACKGROUND: Methylprednisolone (MPD) is a rapid acting highly effective cluster headache preventive and also suppresses the recurrence of migraine attacks. Previously, we could demonstrate that elevated CGRP plasma levels in a cluster headache bout are normalized after a course of high dose corticos...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773314/ https://www.ncbi.nlm.nih.gov/pubmed/26931452 http://dx.doi.org/10.1186/s10194-016-0609-x |
_version_ | 1782418718400184320 |
---|---|
author | Neeb, Lars Hellen, Peter Hoffmann, Jan Dirnagl, Ulrich Reuter, Uwe |
author_facet | Neeb, Lars Hellen, Peter Hoffmann, Jan Dirnagl, Ulrich Reuter, Uwe |
author_sort | Neeb, Lars |
collection | PubMed |
description | BACKGROUND: Methylprednisolone (MPD) is a rapid acting highly effective cluster headache preventive and also suppresses the recurrence of migraine attacks. Previously, we could demonstrate that elevated CGRP plasma levels in a cluster headache bout are normalized after a course of high dose corticosteroids. Here we assess whether MPD suppresses interleukin-1β (IL-1β)- and prostaglandin E(2) (PGE(2))-induced CGRP release in a cell culture model of trigeminal ganglia cells, which could account for the preventive effect in migraine and cluster headache. Metoprolol(MTP), a migraine preventive with a slow onset of action, was used for comparison. METHODS: Primary cultures of rat trigeminal ganglia were stimulated for 24 h with 10 ng/ml IL-1β or for 4 h with 10 μM PGE(2) following the exposure to 10 or 100 μM MPD or 100 nM or 10 µM MTP for 45 min or 24 h. CGRP was determined by using a commercial enzyme immunoassay. RESULTS: MPD but not MTP blocked IL-1β-induced CGRP release from cultured trigeminal cells. PGE(2)-stimulated CGRP release from trigeminal ganglia cell culture was not affected by pre-stimulation whether with MPD or MTP. CONCLUSION: MPD but not MTP suppresses cytokine (IL-1β)-induced CGRP release from trigeminal ganglia cells. We propose that blockade of cytokine mediated trigeminal activation may represent a potential mechanism of action that mediates the preventive effect of MTP on cluster headache and recurrent migraine attacks. |
format | Online Article Text |
id | pubmed-4773314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-47733142016-03-29 Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells Neeb, Lars Hellen, Peter Hoffmann, Jan Dirnagl, Ulrich Reuter, Uwe J Headache Pain Research Article BACKGROUND: Methylprednisolone (MPD) is a rapid acting highly effective cluster headache preventive and also suppresses the recurrence of migraine attacks. Previously, we could demonstrate that elevated CGRP plasma levels in a cluster headache bout are normalized after a course of high dose corticosteroids. Here we assess whether MPD suppresses interleukin-1β (IL-1β)- and prostaglandin E(2) (PGE(2))-induced CGRP release in a cell culture model of trigeminal ganglia cells, which could account for the preventive effect in migraine and cluster headache. Metoprolol(MTP), a migraine preventive with a slow onset of action, was used for comparison. METHODS: Primary cultures of rat trigeminal ganglia were stimulated for 24 h with 10 ng/ml IL-1β or for 4 h with 10 μM PGE(2) following the exposure to 10 or 100 μM MPD or 100 nM or 10 µM MTP for 45 min or 24 h. CGRP was determined by using a commercial enzyme immunoassay. RESULTS: MPD but not MTP blocked IL-1β-induced CGRP release from cultured trigeminal cells. PGE(2)-stimulated CGRP release from trigeminal ganglia cell culture was not affected by pre-stimulation whether with MPD or MTP. CONCLUSION: MPD but not MTP suppresses cytokine (IL-1β)-induced CGRP release from trigeminal ganglia cells. We propose that blockade of cytokine mediated trigeminal activation may represent a potential mechanism of action that mediates the preventive effect of MTP on cluster headache and recurrent migraine attacks. Springer Milan 2016-03-01 /pmc/articles/PMC4773314/ /pubmed/26931452 http://dx.doi.org/10.1186/s10194-016-0609-x Text en © Neeb et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Article Neeb, Lars Hellen, Peter Hoffmann, Jan Dirnagl, Ulrich Reuter, Uwe Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells |
title | Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells |
title_full | Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells |
title_fullStr | Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells |
title_full_unstemmed | Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells |
title_short | Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells |
title_sort | methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773314/ https://www.ncbi.nlm.nih.gov/pubmed/26931452 http://dx.doi.org/10.1186/s10194-016-0609-x |
work_keys_str_mv | AT neeblars methylprednisoloneblocksinterleukin1betainducedcalcitoningenerelatedpeptidereleaseintrigeminalgangliacells AT hellenpeter methylprednisoloneblocksinterleukin1betainducedcalcitoningenerelatedpeptidereleaseintrigeminalgangliacells AT hoffmannjan methylprednisoloneblocksinterleukin1betainducedcalcitoningenerelatedpeptidereleaseintrigeminalgangliacells AT dirnaglulrich methylprednisoloneblocksinterleukin1betainducedcalcitoningenerelatedpeptidereleaseintrigeminalgangliacells AT reuteruwe methylprednisoloneblocksinterleukin1betainducedcalcitoningenerelatedpeptidereleaseintrigeminalgangliacells |